Home Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer
 

Keywords :   


Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer

2014-06-04 12:52:32| drugdiscoveryonline News Articles

Novogen Limited (NASDAQ: NVGN, ASX:NRT), an oncology drug development company, today announced that it has achieved a key milestone with its super-benzopyran (SBP) drug program, having identified a number of SBP compounds with potent anti-cancer activity against human prostate cancer cells in vitro

Tags: active highly drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »